Kalaris Therapeutics Inc (KLRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 61,084 | N/A | N/A | N/A |
| Marketable Securities | 64,993 | N/A | N/A | N/A |
| Receivables | 298 | N/A | N/A | N/A |
| Other current assets | 262 | 0 | 0 | 0 |
| TOTAL | $127,313 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 350 | N/A | N/A | N/A |
| Other Non-Current Assets | 11,759 | 0 | 0 | 0 |
| TOTAL | $12,109 | $N/A | $N/A | $N/A |
| Total Assets | $139,422 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 630 | 0 | 0 | 0 |
| Accrued Expenses | 5,163 | N/A | N/A | N/A |
| Other current liabilities | 246 | N/A | N/A | N/A |
| TOTAL | $9,106 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 181,819 | 0 | 0 | 0 |
| TOTAL | $181,819 | $N/A | $N/A | $N/A |
| Total Liabilities | $190,925 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -55,319 | N/A | N/A | N/A |
| Other shareholders' equity | 68 | 0 | 0 | 0 |
| TOTAL | $-51,503 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $139,422 | $0 | $0 | $0 |